Cutting edge: TGF-beta signaling is required for the in vivo expansion and immunosuppressive capacity of regulatory CD4 CD25 T cells
Journal of immunology. Bd. 173. H. 11. Bethesda: American Assoc. of Immunologists 2004 S. 6526 - 6531
Erscheinungsjahr: 2004
ISBN/ISSN: 0022-1767 ; 1048-3233 ; 1047-7381
Publikationstyp: Zeitschriftenaufsatz
Sprache: Englisch
| Geprüft: | Bibliothek |
Inhaltszusammenfassung
Data regarding the role of TGF-beta for the in vivo function of regulatory CD4( )CD25( ) T cells (Treg) are controversial. A transgenic mouse model with impaired TGF-beta signaling specifically in T cells was used to assess the role of endogenous TGF-beta for the in vivo function of CD4( )CD25( ) Treg in a murine model of colitis induced by dextran sulfate. Transfer of wild-type, but not transgenic CD4( )CD25( ) Treg was found to suppress colitis in wild-type mice. In addition, by transferrin...Data regarding the role of TGF-beta for the in vivo function of regulatory CD4( )CD25( ) T cells (Treg) are controversial. A transgenic mouse model with impaired TGF-beta signaling specifically in T cells was used to assess the role of endogenous TGF-beta for the in vivo function of CD4( )CD25( ) Treg in a murine model of colitis induced by dextran sulfate. Transfer of wild-type, but not transgenic CD4( )CD25( ) Treg was found to suppress colitis in wild-type mice. In addition, by transferring CFSE-labeled CD4( )CD25( ) Treg we could demonstrate that endogenous TGF-beta promotes the expansion of CD4( )CD25( ) Treg in vivo. Transgenic mice themselves developed reduced numbers of peripheral CD4( )CD25( ) Treg and were more susceptible to the induction of colitis, which could be prevented by the transfer of wild-type Treg. These data indicate that TGF-beta signaling in CD4( )CD25( ) Treg is required for their in vivo expansion and suppressive capacity.» weiterlesen» einklappen
Autoren
Klassifikation
DDC Sachgruppe:
Medizin